The Polymorphism of Metabolic and Immune Mechanisms Controlling Genes in Type 2 Diabetes Mellitus
Genes · 2025
DOI: 10.3390/genes16091116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Iuliana Shramko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Clinical Pathophysiology, Order of the Red Banner of Labor S.I. Georgievsky Medical Institute of the Federal State Autonomo…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Polymorphism, Single Nucleotide, Metabolic Syndrome. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: V.I. Vernadsky Crimean Federal University, V. I. Vernadsky Crimean Federal University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Most genes involved in the pathogenesis of Metabolic Syndrome (MS) and Type 2 Diabetes Mellitus (T2DM) are regulated by peroxisome proliferator-activated receptors (PPARs), which modulate the production of pro-inflammatory cytokines, with interleukin-6 (IL-6) playing a crucial role. The associations of single-nucleotide polymorphisms (SNPs) with MS and T2DM remain uncertain across populations. Therefore, we aimed to investigate the associations of PPAR-related SNPs in IL-6, LEP, ADIPOQ, ADIPOR1, and ADIPOR2 with MS and T2DM clinical features.
Methods
Polymorphism analysis of IL-6, LEP, ADIPOQ, ADIPOR1, and ADIPOR2 genes was performed on isolated DNA from individuals diagnosed with T2DM and from healthy controls using real-time polymerase chain reaction (qPCR).
Results
The IL-6-174G/C polymorphism shows that the CC genotype is associated with higher MS risk, whereas the GG genotype appears protective against metabolic disturbances. When the IL6 CC genotype is combined with ADIPOR2 GA or ADIPOR2 219 A/T, hyperglycemia is 1.3 times more frequent than with other IL6/ADIPOR2 genotype combinations.
Conclusions
To develop informative genetic risk scores, future studies should include additional polymorphisms in key immune–metabolic pathway genes, such as AP-1, NF-κB, and FFAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General and Clinical Pathophysiology, Order of the Red Banner of Labor S.I. Georgievsky Medical Institute of the Federal State Autonomous Educational Institution of Higher Education, V. I. Vernadsky Crimea…
- Department of Medical Biology, Order of the Red Banner of Labor S.I. Georgievsky Medical Institute of the Federal State Autonomous Educational Institution of Higher Education, V. I. Vernadsky Crimean Federal University,…
- Center for the Collective Use of Scientific Equipment "Molecular Biology", V. I. Vernadsky Crimean Federal University, Lenin boulevard, 5/7, 295000 Simferopol, Russia.
ORCID-Profile: Iuliana Shramko, Elizaveta Ageeva, Anatolii Kubishkin, Tatyana Makalish, Cyrill Tarimov
Förderung
- V.I. Vernadsky Crimean Federal University
- V. I. Vernadsky Crimean Federal University
Zitieren
APA
Shramko, I., Ageeva, E., Kubishkin, A., Makalish, T., Tarimov, C., & Bondar', D. (2025). The Polymorphism of Metabolic and Immune Mechanisms Controlling Genes in Type 2 Diabetes Mellitus. Genes. https://doi.org/10.3390/genes16091116
Vancouver
Shramko I, Ageeva E, Kubishkin A, Makalish T, Tarimov C, Bondar' D. The Polymorphism of Metabolic and Immune Mechanisms Controlling Genes in Type 2 Diabetes Mellitus. Genes. 2025. doi:10.3390/genes16091116
BibTeX
@article{Shramko2025,
author = {Shramko, Iuliana and Ageeva, Elizaveta and Kubishkin, Anatolii and Makalish, Tatyana and Tarimov, Cyrill and Bondar', Dmitry},
title = {The Polymorphism of Metabolic and Immune Mechanisms Controlling Genes in Type 2 Diabetes Mellitus},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16091116}
}
EUVIMED